Skip to main content
Unchecking box will stop auto data updates
Delayed Price USD
Today's Change
Volume
Price Quote as of

Today's Trading

Day Low 1.700
Day High 1.770
Open:1.760
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Trailing Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
The Supreme Cannabis Co Inc is engaged in production and sale of medical cannabis. The company is a cultivator and distributor of sun-grown cannabis through its wholly-owned subsidiary 7ACRES.

Fundamentals

Market Capitalization, $M
Shares Outstanding, M
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Zacks Investment Research, including Income Statements, Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research – including Buy/Hold Recommendations, Earnings Surprises, Estimates and Recommendations History.

Stock Reports +

Download a comprehensive report detailing quantitative analytics of this equity. For subscribers only.

Latest Press Releases

Diversified Strategies to Handle Domestic and International Expansion in Booming Cannabis Market
PR Newswire - Thu Nov 15, 7:30AM CST
PR Newswire - CMTX
Thu Nov 15, 7:30AM CST
FinancialNewsMedia.com News Commentary
MediPharm Labs Signs The Supreme Cannabis Company for Cannabis Concentrate Program
GlobeNewswire - Wed Nov 14, 6:00AM CST
GlobeNewswire - CMTX
Wed Nov 14, 6:00AM CST
MediPharm Labs Corp. (TSXV: LABS) (the "Company" or "MediPharm Labs") is pleased to announce that its wholly owned subsidiary MediPharm Labs Inc. ("MediPharm") has entered into a Cannabis Concentrate Program Agreement (the "Agreement") with The Supreme Cannabis Company, Inc. ("Supreme Cannabis") (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1). Pursuant to the Agreement signed on November 13, 2018, the parties have entered into a commercial arrangement whereby Supreme Cannabis will provide MediPharm with dried cannabis to use for the purposes of creating cannabis oil (the "Program"). The Program will be for an initial term of three years.
Supreme Cannabis Announces Record Revenues For Q1 2019
- CNW Group - Wed Nov 14, 6:00AM CST
CNW Group - CMTX
Wed Nov 14, 6:00AM CST
The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1), announced the release of its financial and operating results for the three months ended September 30, 2018.
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 1.290 +34.11% increase
on 10/23/18
Period Open:2.070
Price movement based on the high, low and last over the given period.
2.050 -15.61% decrease
on 10/18/18
-0.340 (-16.43%) decrease
since 10/16/18
3-Month 1.290 +34.11% increase
on 10/23/18
Period Open:1.420
Price movement based on the high, low and last over the given period.
2.430 -28.81% decrease
on 09/26/18
+0.310 (+21.83%) increase
since 08/16/18
52-Week 1.250 +38.40% increase
on 08/14/18
Period Open:1.470
Price movement based on the high, low and last over the given period.
3.490 -50.43% decrease
on 01/03/18
+0.260 (+17.69%) increase
since 11/16/17

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2018.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

More stories below advertisement